Bryan Turner, MD
General Practice · South Jordan, UTNPI 1700834991
Payments from drug & device makers
Across 18 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Idorsia Pharmaceuticals US Inc$101
- Collegium Pharmaceutical, Inc.$27
- Xeris Pharmaceuticals, Inc.$23
- Vertex$17
- Medtronic$15
- Sanofi$15
- plus $82 from 6 others
What the payments were for
- Food & beverage$281100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Idorsia Pharmaceuticals US Inc | 6 | $101 |
| Collegium Pharmaceutical, Inc. | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Vertex | 1 | $17 |
| Medtronic | 1 | $15 |
| Sanofi | 1 | $15 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Exact Sciences | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $13 |
| Medline Industries LP | 1 | $13 |
How this compares
$281 in reported general payments places this provider in the 50th percentile of 1,070 general practice providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 33 | $38,040 |
| OzempicSemaglutide | 24 | $25,269 |
| MounjaroTirzepatide | 15 | $13,726 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $8,214 |
| Oxycodone Hcl | 110 | $3,912 |
| Adderall XrDextroamphetamine/Amphetamine | 12 | $2,520 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 70 | $2,046 |
| Armour ThyroidThyroid,pork | 20 | $1,751 |
| Colchicine | 21 | $1,480 |
| Hydromorphone Hcl | 25 | $1,236 |
| Testosterone Cypionate | 25 | $1,203 |
| Liothyronine Sodium | 32 | $1,144 |
| Fentanyl | 11 | $1,121 |
| Potassium Chloride | 25 | $987 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 14 | $832 |
Paid to pharmacies, not to this prescriber.
Other general practice in South Jordan
- Ryan LewisSouth Jordan$735K
- Gregory BairdSouth Jordan$34K
- Walter MedenSouth Jordan$12K
- James AndersonRoy$44.1M
- Dan FischerSandy$8.1M
- Jaleena JessopSandy$6.7M
- Melanie HoppersMurray$1.2M
- Mark LudlowWest Jordan$592K
- Eric SwensenWest Jordan$109K
- Brigham StokerSalt Lake City$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.